Cybin
Cybin is focused on progressing psychedelic therapeutics by utilizing proprietary drug discovery platforms. Learn more
Launch date
Employees
Market cap
AUD225m
Enterprise valuation
AUD16m (Public information from Sep 2024)
Share price
$8.56 CYBN
Ontario California (HQ)
Authorizing premium user...